ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,039,478 | +175.3% | 150,600 | +118.3% | 2.47% | +217.5% |
| Q2 2023 | $26,891,370 | -50.1% | 69,000 | -87.7% | 0.78% | -62.1% |
| Q4 2018 | $53,889,000 | +26.7% | 560,941 | 0.0% | 2.05% | +80.2% |
| Q3 2018 | $42,541,000 | -3.0% | 560,941 | +5.9% | 1.14% | -1.0% |
| Q2 2018 | $43,879,000 | +1.5% | 529,560 | -1.5% | 1.15% | -5.0% |
| Q1 2018 | $43,225,000 | +27.4% | 537,361 | 0.0% | 1.21% | +7.6% |
| Q4 2017 | $33,929,000 | +68.0% | 537,361 | -40.3% | 1.12% | +191.5% |
| Q3 2017 | $20,196,000 | +111.6% | 900,000 | +100.0% | 0.39% | -19.6% |
| Q2 2017 | $9,544,000 | – | 450,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |